Viewing Study NCT03776032


Ignite Creation Date: 2025-12-24 @ 10:00 PM
Ignite Modification Date: 2026-01-02 @ 4:37 AM
Study NCT ID: NCT03776032
Status: COMPLETED
Last Update Posted: 2018-12-20
First Post: 2018-12-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Novel Erythropoiesis Stimulating Protein (NESP; Darbopoetin Alfa) for the Treatment of Anemia in Lung Cancer Patients Receiving Multi-cycle Platinum-Containing Chemotherapy
Sponsor: Amgen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module